Evolus Study Unveils Millennial Botox Triumph

This episode delves into a new study revealing that prabotulinumtoxinA, a type of Botox, is particularly effective among millennials. Dr. Rui Avelar, head of research and development at Evolus, shares insights from a post hoc analysis of 737 adults treated for glabellar lines. While over 90% of nonmillennials responded well, 100% of millennials saw positive results, with satisfaction rates exceeding 98% at various checkpoints. The episode explores why millennials may experience higher effecti...